08

Home >> 2024 >> March >> 08

f.l.t.r. Prof. Madeja, Chairman EKFS Management Board; F. Mohrs, Lower Saxony's Minister Science & Culture; Prof. Brück, Dean Medical Faculty; Dr. Dangmann, Member EKFS Management Board; Prof. Moser, Auditory Neuroscience UMG. Photo: UMG/spförtner

08.03.2024

Else Kröner Fresenius Center for Optogenetic Therapies approved

Else Kröner-Fresenius-Stiftung (EKFS) supports new research center for optogenetic therapies with 37.4 million euros over ten years at the University Medical Center Göttingen (UMG). The state of Lower Saxony is strongly supporting the establishment of the center and, together with the UMG, is holding out the prospect of up to
Learn More

f.l.t.r. Prof. Madeja, Chairman EKFS Management Board; F. Mohrs, Lower Saxony's Minister Science & Culture; Prof. Brück, Dean Medical Faculty; Dr. Dangmann, Member EKFS Management Board; Prof. Moser, Auditory Neuroscience UMG. Photo: UMG/spförtner

08.03.2024

Else Kröner Fresenius Center for Optogenetic Therapies approved

Else Kröner-Fresenius-Stiftung (EKFS) supports new research center for optogenetic therapies with 37.4 million euros over ten years at the University Medical Center Göttingen (UMG). The state of Lower Saxony is strongly supporting the establishment of the center and, together with the UMG, is holding out the prospect of up to
Learn More
Feature image not available
08.03.2024

Synphilin-1 as a modulator of aSyn assembly

Authors Lázaro DF, Amen T, Gerhardt E, Santos PI, Milovanovic D, Höglinger G, Outeiro TF Journal BioRxiv Citation bioRxiv 2024.03.05.583522. Abstract Alpha-synuclein (aSyn) is an intrinsically disordered protein that undergoes phase-separation and is associated with several neurodegenerative conditions. However, the function and the pathological role of aSyn are still elusive.
Learn More
X

Open Positions

Junior Fellow (f/m/d)

x
EN DE
X
X